共 21 条
Multiplexed detection and differentiation of the DNA strains for influenza A (H1N1 2009) using a silicon-based microfluidic system
被引:49
作者:
Kao, Linus Tzu-Hsiang
[1
]
Shankar, Lakshmi
[1
]
Kang, Tae Goo
[1
]
Zhang, Guojun
[1
]
Tay, Guang Kai Ignatius
[1
]
Rafei, Siti Rafeah Mohamed
[1
]
Lee, Charlie Wah Heng
[2
]
机构:
[1] ASTAR, Inst Microelect, Singapore 117685, Singapore
[2] ASTAR, Genome Inst Singapore, Singapore 138672, Singapore
关键词:
Swine flu (H1N1 2009);
Microfluidic PCR;
Silicon nanowire;
Point-of-care diagnosis;
NUCLEIC-ACID AMPLIFICATION;
NANOWIRE;
PCR;
TRANSISTOR;
D O I:
10.1016/j.bios.2010.08.076
中图分类号:
Q6 [生物物理学];
学科分类号:
071011 ;
摘要:
Pandemic influenza by the swine-origin influenza virus (H1N1 2009) has attracted considerable concern worldwide. A convenient and accurate diagnostic approach that can be deployed at the point of care, such as in a doctor's office or at an airport, is critical for disease control. Here we report the development of a silicon-based microfluidic system for subtype differentiation of the novel H1N1 2009 strain vs. the seasonal influenza A (FluA) strain. The proposed system included two functional modules: a multiplexed PCR module for amplification of nucleic acid targets and a multiplexed silicon nanowire (SiNW) module for sequence determination. The PCR module consisted of a microfluidic PCR chamber and an electrical controller to perform a multiplexed protocol that simultaneously enriched specific segments of both H1N1 and FluA strains (if present), with 10(4)-10(5) amplification efficiency. The PCR amplicon was subsequently denatured and transferred to the SiNW sensing module for a label-free, multiplexed detection. A control SiNW was implemented, for the first time, in order to eliminate background interference. The detection module demonstrated a 10x change in the magnitude of differential current when the target DNA was injected. Overall, the system achieved a sensitivity of 20-30 fg/mu I for H1N1 and seasonal FluA nucleic acids in a 10 mu l sample. The low sample consumption, high sensitivity and high specificity render it a potential point-of-care (POC) platform to help doctors reach a yes/no decision for infectious diseases. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:2006 / 2011
页数:6
相关论文